Cita APA

Rosenberg, J. E., Bambury, R., Drabkin, H. A., Lara, P. N., Harzstark, A. L., Figlin, R. A., . . . Laber, D. A. (2013). A phase II trial of the nucleolin-targeted DNA aptamer AS1411 in metastatic refractory renal cell carcinoma. Invest New Drugs.

Citación estilo Chicago

Rosenberg, Jonathan E., et al. "A Phase II Trial of the Nucleolin-targeted DNA Aptamer AS1411 in Metastatic Refractory Renal Cell Carcinoma." Invest New Drugs 2013.

Cita MLA

Rosenberg, Jonathan E., et al. "A Phase II Trial of the Nucleolin-targeted DNA Aptamer AS1411 in Metastatic Refractory Renal Cell Carcinoma." Invest New Drugs 2013.